Evidence map›Paper›PMID 32996080›Full record

ArticleMolecular and cellular biochemistry2021

Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-146a/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy.

Wei Ren, Guangxia Xi, Xing Li, Lingxia Zhao, Kun Yang, Xuemei Fan, Linlin Gao, Hongmei Xu, Jianjin Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. The role of long non-coding RNA HCG18 in cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wei RenDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Guangxia XiDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Xing LiDepartment of Endocrinology and Metabolism, The Second Clinical Medical College of Shanxi Medical University, The Second Hospital of Shanxi Medical University, No. 382, WuYi Road, Taiyuan City, 030001, Shanxi Province, China.
Lingxia ZhaoDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Kun YangDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Xuemei FanDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Linlin GaoDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Hongmei XuDepartment of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, No. 99, Longcheng Street, Taiyuan City, 030032, Shanxi Province, China.
Jianjin GuoDepartment of Endocrinology and Metabolism, The Second Clinical Medical College of Shanxi Medical University, The Second Hospital of Shanxi Medical University, No. 382, WuYi Road, Taiyuan City, 030001, Shanxi Province, China. guojianjin235@163.com.ORCID http://orcid.org/0000-0002-6529-1545
Shanxi Academy of Medical Sciences · CNShanxi Medical University · CN

Funding

Scientific Research Foundation for outstanding youth of Shanxi Bethune Hospital 2019YJ09The Science Foundation of Health Commission of Shanxi Province 201601052The Science Foundation of Health Commission of Shanxi Province 20161004The Science Foundation of Health Commission of Shanxi Province 2018GW26
6 · The paper itself

Abstract

Diabetic peripheral neuropathy (DPN) is one of the most important complications in diabetes mellitus (DM), which has been reported to be modulated by long non-coding RNAs (lncRNAs). The purpose of the current study is to explore the regulatory mechanism of lncRNA HCG18 on DPN in vitro. The expression of lncRNA HCG18, miR-146a, TRAF6, CD11c, and iNOS was detected by qRT-PCR. Through Enzyme-linked immunosorbent assay, the levels of inflammatory factors (TNF-α, IL-1β, and IL-6) were determined. M1 macrophage polarization was measured by flow cytometry analysis. The interactions between miR-146a and HCG18/TRAF6 were predicted by Starbase/Targetscan software and verified by the dual luciferase reporter assay. Western blot assay was performed to determine the protein expression of TRAF6. LncRNA HCG18 was highly expressed in DPN model and HG-induced macrophages. The levels of inflammatory factors (TNF-α, IL-1β, and IL-6) were elevated in DPN model. The expression of M1 markers (CD11c and iNOS) was visibly up-regulated in DPN model and was positively correlated with HCG18 expression. LncRNA HCG18 facilitated M1 macrophage polarization. In addition, miR-146a was identified as a target of lncRNA HCG18. Overexpression of miR-146a reversed the promoting effect of HCG18 on M1 macrophage polarization. Simultaneously, TRAF6 was a target gene of miR-146a TRAF6 expression was positively modulated by HCG18 and was negatively modulated by miR-146a. Down-regulation of TRAF6 reversed the promoting effect of HCG18 on M1 macrophage polarization. LncRNA HCG18 promotes M1 macrophage polarization via regulating the miR-146a/TRAF6 axis, facilitating the progression of DPN. This study provides a possible therapeutic strategy for DPN.

Indexed as

Cell PolarityAnimalsDiabetic NeuropathiesDisease ProgressionInflammationMacrophage ActivationMacrophagesMiceMicroRNAsRatsRats, Sprague-DawleyRAW 264.7 CellsRNA, Long NoncodingTNF Receptor-Associated Factor 6MicroRNAsMirn146 microRNA, mouseMIRN146 microRNA, ratRNA, Long NoncodingTNF Receptor-Associated Factor 6TRAF6 protein, mouseDiabetic peripheral neuropathylncRNA HCG18Macrophage polarizationmiR-146aTRAF6

Identifiers

PMID32996080
OpenAlexW3090716279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.